Health & Medical Innovation Grants

The objective of the Ideas Grant scheme is to support innovative research projects addressing specific question(s). The expected outcomes are: • innovative and creative research • funding of researchers at all career stages • funding any area of health and medical research from discovery to implementation. It is expected that the CIA will have the capability to lead the team in achieving the project aims. Only applications that address the intended objective and outcomes will be competitive for funding. The Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective, and applications meeting that description should be submitted to the Clinical Trial and Cohort Studies Grant scheme. Where applications have elements consistent with both the Clinical Trials and Cohort Studies Grant scheme and the Ideas Grant scheme, applicants should decide where the project is predominantly suited, based on the objectives and intended outcomes of

A venture capital investment program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

A legislated tax offset program that supports companies to invest in eligible research and development by offsetting some of the associated costs. The program provides refundable or non-refundable tax offsets based on company turnover and R&D expenditure proportions, with offsets up to $150 million.

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes. The objectives of the Partnership Project scheme are to: • Meet the need for more effective integration of research evidence into health policy and service delivery • Create partnerships among policy makers, managers, service providers and researchers • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care • Be highly responsive to the priorities of government, the community and health professionals • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. Eligibility: Appications will only be accepted from NHMRC approved Administering Institut

Grants to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. The program funds eligible organisations to identify, select and support Australian SMEs undertaking early-stage medical research and innovation projects with commercial potential in areas such as biomarkers, diagnostics, therapeutics, assistive devices and digital technologies.

This grant program supports researchers pursuing innovative projects to develop new products and interventions in health and medical research, with the goal of creating treatments for serious and incurable health conditions. Funding supports programs of research comprising linked projects with a 10-year time horizon, from proof-of-concept through to full clinical implementation.

A $10 million research funding initiative supporting high-quality research into the health and wellbeing of serving and ex-serving Australian Defence Force members. The program aims to generate evidence and develop practical, implementable actions to improve mental and physical health outcomes, with consideration for support networks including family, dependants and carers. Research must focus on translation and implementation, prevention and early intervention strategies, and collaborative multidisciplinary approaches.

This grant program provides financial assistance to support medical research and medical innovation projects focused on genomics and precision medicine. It funds six streams of research including development of genomic tools for cancer screening, gene discovery research, polygenic risk score methods for disease identification, clinical genomics implementation, and research infrastructure for data sharing and collaboration across Australia.

Living organ donation is major surgery and carries risk for the donor. Prospective donors undergo extensive work-up testing to ensure they are physically and mentally able to donate, and these medical appointments may require donors to take time off work. If donation surgery proceeds, donors may require a significant amount of time off work to recover. The extensive work-up testing and donation surgery may require donors to travel long distances for medical appointments. The program aims to ensure that taking time off work and out-of-pocket travel and accommodation expenses are not a barrier for individuals considering donation. The program provides reimbursement of paid leave and out-of-pocket expenses associated with donation. The program is not an incentive to donate. It is designed to help support those individuals who wish to donate but cannot afford to due to loss of income and the financial stress it would cause for them and their family. The purpose of the program is to reduce

The 2026 NHMRC-Swiss National Science Foundation (SNSF) grant opportunity supports Australian participation in an international collaboration with Switzerland through the Australian - Swiss Joint Research Programme Call for Proposals 2026. NHMRC is working with SNSF to support Joint Research Projects to promote collaborative projects with clearly defined goals, involving at least one partner based in Switzerland and one based in Australia. The research field for this collaboration is: Artificial Intelligence (AI) in healthcare for populations of diverse sex, gender or sexual orientations or other underrepresented population groups. Applicants are required to justify how their target population is considered underrepresented in the context of this funding opportunity. Possible topics include but are not limited to: • AI for medical decision support for diagnosis and treatment planning, with a focus of underrepresented population groups • Addressing bias in medical training data • Enhanc

This grant funds implementation research that maximizes collaboration and coordination with sectors and settings beyond the healthcare system to tackle chronic non-communicable diseases in low- and middle-income countries and/or underserved populations in high-income countries. For Australian funding, research must focus on Aboriginal and/or Torres Strait Islander communities. The grant supports strategies leveraging opportunities provided by settings and sectors beyond the health system while facilitating collaboration with relevant healthcare systems.

This grant supports implementation research that maximizes collaboration across sectors and settings beyond the healthcare system to address chronic non-communicable diseases in underserved populations. Proposals should focus on strategies leveraging opportunities in low- and middle-income countries (LMICs) and/or for Aboriginal and Torres Strait Islander communities in Australia, with expected collaboration from relevant healthcare systems.